<DOC>
	<DOCNO>NCT02150590</DOCNO>
	<brief_summary>The purpose study investigate effect nocturnal oxygen therapy stay moderate altitude breathe sleep patient chronic obstructive lung disease .</brief_summary>
	<brief_title>Patients With Chronic Obstructive Pulmonary Disease Altitude - Effect Nocturnal Oxygen Breathing Sleep</brief_title>
	<detailed_description>Patients moderate severe chronic obstructive pulmonary disease live 800 invited participate randomize , cross-over field trial evaluate hypothesis nocturnal breathing sleep night spend moderate altitude improve oxygen therapy via nasal cannula compare room air ( sham oxygen ) . Outcomes assess low altitude ( Zurich , 490 , baseline ) , 2 study period 2 night spend moderate altitude ( St. Moritz Salastrains , 2048 ) separate wash-out period least 2 week spend low altitude ( &lt; 800 ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>chronic obstructive pulmonary disease ( COPD ) , GOLD grade 23 resident low altitude ( &lt; 800 ) unstable condition , COPD exacerbation mild ( GOLD 1 ) severe COPD ( GOLD 4 ) requirement oxygen therapy low altitude residence hypoventilation pulmonary hypertension mild unstable cardiovascular disease use drug affect respiratory center drive internal , neurologic psychiatric disease interfere protocol compliance include current heavy smoking ( &gt; 20 cigarette per day ) , inability perform 6 min walk test . previous intolerance moderate altitude ( &lt; 2600m ) . exposure altitudes &gt; 1500m &gt; 2 day within last 4 week study . pregnant nursing patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>airway disease</keyword>
	<keyword>bronchitis</keyword>
	<keyword>emphysema</keyword>
	<keyword>lung</keyword>
</DOC>